Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
NextCure, Inc. (NXTC)
|
Add to portfolio |
|
|
|
| Price: |
$6.07
| | Metrics |
| OS: |
27.8
|
M
| |
|
|
| Market cap: |
$169
|
M
| |
|
|
|
Net cash:
|
$22
|
M
| |
$0.79
|
per share
|
|
EV:
|
$147
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($71.2)
|
M
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| Revenues | 0.0 | 0.0 | 22.4 | 6.3 | 0.0 | 0.0 |
| Revenue growth | | -100.0% | 252.6% | | | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 22.4 | 6.3 | 0.0 | 0.0 |
| Gross margin | | | 100.0% | 100.0% | | |
| Research and development | 54.2 | 50.2 | 46.6 | 34.2 | 19.8 | 13.0 |
| General and administrative | 21.7 | 20.6 | 17.0 | 9.6 | 3.4 | 2.6 |
| EBIT | -75.9 | -70.8 | -41.2 | -37.5 | -23.2 | -15.5 |
| EBIT margin | | | -184.2% | -590.5% | | |
| Pre-tax income | -74.7 | -69.4 | -36.6 | -33.7 | -22.8 | -15.5 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -74.7 | -69.4 | -36.6 | -33.7 | -22.8 | -15.5 |
| Net margin | | | -163.6% | -531.5% | | |
| |
| Diluted EPS | ($2.69) | ($2.51) | ($1.33) | ($2.15) | ($16.64) | ($11.30) |
| Shares outstanding (diluted) | 27.7 | 27.6 | 27.5 | 15.7 | 1.4 | 1.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|